News

Building on Cornell’s decades of fundamental and comparative research in the immunological sciences, Provost Michael Kotlikoff has announced the creation of a new Cornell Center for Immunology.

Diffuse Intrinsic Pontine Glioma (DIPG) is every parent’s worst nightmare: a rare and incurable type of brain cancer that affects young children. Dr. Mark Souweidane decided to make curing this cancer his “Holy Grail”—and his progress since then has been impressive.

Chelsea Clinton is a public health advocate, researcher and educator. But being a mother has deepened her passion for children’s health, she explained in a talk on Feb. 5 at Weill Cornell Medicine.

An investigation by Weill Cornell Medicine scientists has yielded two breakthroughs in the pursuit of combating growing resistance to tuberculosis treatments. 

Dr. Joseph J. Fins, chief of the Division of Medical Ethics at Weill Cornell Medicine, has been awarded the Nicholas E. Davies Memorial Scholar Award from the American College of Physicians, a national organization of internists.

Treating patients with advanced, metastatic esophageal cancer with an immune-system boosting drug called pembrolizumab, known by its brand name Keytruda, led to regression of tumors in some patients, according to results of a phase 2 clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators.

A recent alumna runs the World Marathon Challenge

Awards, honors, prizes and achievements for the month of January.

New studies from Weill Cornell Medicine researchers have revealed the importance of two gene-regulation proteins in the development of common immune cell cancers called lymphomas.

Dr. Lisa Newman and her multidisciplinary research team study why breast cancer outcomes vary by patients’ race and ethnicity.

How a soap opera inspired this leading breast cancer surgeon and researcher.

Researchers at WCM–Qatar hope to help Qatar curb its looming diabetes crisis.

A rapid, non-invasive eye exam that uses innovative imaging technology effectively measures the severity of disease in patients with a rare neurodegenerative disease called Friedrich ataxia, according to a study by Weill Cornell Medicine, Weill Cornell Medicine-Qatar and NewYork-Presbyterian researchers.

Dr. Barbara Hempstead, a preeminent physician-scientist, educator and academic leader, has been appointed dean of the Weill Cornell Graduate School of Medical Sciences, effective Jan. 14.

Researchers at Weill Cornell Medicine, in collaboration with investigators at Dana-Farber Cancer Institute, have been awarded a three-year, $1 million grant from the U.S. Department of Defense (DoD) for prostate cancer clinical trials.

An innovation in gene-splicing technology lands MD-PhD student Dr. Alex Pérez, PhD ’17, on Forbes’s ‘30 Under 30’ list.

Awards, honors, prizes and achievements for the month of December.

Dr. Carlo Canepa spent an Everest climbing season practicing emergency medicine at one of the world’s highest clinics

The death rate of children whose mothers have died from breast or cervical cancer may be as high as 30 percent in some developing countries, according to a new paper published Nov. 1 in Cancer by Weill Cornell Medicine and NewYork-Presbyterian researchers. 

Seven Weill Cornell Medicine faculty members leading multi-institutional research teams were awarded grants from The Starr Foundation's 12th Starr Cancer Consortium Grant Competition to fund their innovative cancer research projects.